Back to catalog
Run Time:
Tue, 10/20/2026 - 7:30am
Duration:
60-minutes
CME Credits:
1.0 AMA PRA Category 1 Credit(s)TM
Cost:
Free
Dennis Dietzen, PhD

PCH - Schrodinger’s Drug Screen: Reducing Uncertainty in Pediatric Toxicology

Led By
Dennis Dietzen, PhD

At the end of this presentation, participants should be able to:

  • List the variety of testing strategies employed in clinical toxicology testing
  • Discuss the potential false-positive and false-negative risks associated with these analytic strategies
  • Assess the role of rapid mass spectrometry in remediating current limitations in toxicology testing

 


 

Delayed CME credit is available for up to 4 weeks following the live session
Please note: providers must be affiliated with Phoenix Children's (medical staff and referring) 
 

Watch Eligible Videos

Claim CME credit

 


 

About this presenter:

Dennis Dietzen, PhD
Division Chief, Pathology | Phoenix Children’s
 

Dennis Dietzen, PhD, is a specialist in pathology and laboratory medicine with specialized training in clinical chemistry, clinical toxicology, mass spectrometry and the diagnosis of inborn errors of metabolism. He serves as Division Chief of Pathology and Laboratory Medicine at Phoenix Children's.

Dr. Dietzen earned his bachelor's degree in chemistry from Marian University and his doctorate in biochemistry and molecular biology from Indiana University School of Medicine, both in Indianapolis. He completed a fellowship in clinical chemistry and post-doctoral research at Washington University School of Medicine in St. Louis.

A diplomate of the American Board of Clinical Chemistry, Dr. Dietzen is also past president of the American Association for Clinical Chemistry, now called the Association for Diagnostics & Laboratory Medicine, where he has been highly involved throughout his career and currently chairs the Policy and External Affairs Core committee. He is a member of the Society for Inborn Metabolic Disorders, the Society for Pediatric Research and the Academy of Clinical Laboratory Physicians and Scientists. Dr. Dietzen has served as a professor at several universities, holds numerous hospital affiliations, consults on national advisory boards and has editorial responsibilities for a wealth of medical journals.

Dr. Dietzen is a prolific clinical researcher and has published numerous peer-reviewed papers, written multiple chapters for medical texts and is a regular invited presenter at national conferences. In addition, he has provided congressional briefings on pediatric reference intervals and laboratory-developed tests.

When not at work, Dr. Dietzen enjoys spending time with his family. He is an avid sports fan, golfer and enjoys classical music. 

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Arizona College of Medicine - Tucson and Phoenix Children's. 

The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Arizona College of Medicine - Tucson designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

Relevant Financial Relationships Statement(s):

University of Arizona College of Medicine - Tucson Office of Continuing Medical Education adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). The CME office reviewers have nothing to disclose. All relevant financial relationships have been mitigated prior to the commencement of the activity.

 

Name of individualIndividual's role in activityNature of Relationship(s) / Name of Ineligible Company(s)
Dennis Dietzen, PhD, DABCCFacultyGrant or research support-Abbott (Any division) (Relationship has ended)| Grant or research support-Werfen (Relationship has ended)| Grant or research support-Ascensia (Relationship has ended)|Advisor-BD (Relationship has ended)| Grant or research support-Radiometer (Relationship has ended)| Advisor-Danaher (Relationship has ended)| Advisor-Waters| Royalties or Patent Beneficiary-Elesevier|Royalties or Patent Beneficiary-McGraw-Hill - 09/02/2026
John R Hartley, DO, FAAPActivity DirectorNothing to disclose - 09/29/2026

 

University of Arizona College of Medicine Logo